RT Journal Article
SR Electronic
T1 1053 Preclinical pharmacodynamic characterization of STK-026: a novel IL-12 partial agonist for cancer with maintained CD8 T cell activity, reduced NK-mediated toxicity and an improved therapeutic window
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1160
OP A1160
DO 10.1136/jitc-2023-SITC2023.1053
VO 11
IS Suppl 1
A1 Koliesnik, Zhenya
A1 Totagrande, Michael
A1 Burgess, Ryan
A1 Tran, Kim Q
A1 Bauer, Michele
A1 Jayaraman, Bharghavi
A1 Buffone, Cindy
A1 Balasubrahmanyam, Priyanka
A1 Emmerich, Jan
A1 Chaturvedi, Deepti
A1 Rokkam, Deepti
A1 Malefyt, Rene De Waal
A1 Greb, Heiko
A1 Ratti, Navneet
A1 Vivona, Sandro
A1 Kastelein, Robert
A1 Lupardus, Patrick
A1 Zuniga, Luis
A1 Rosen, David B
A1 Oft, Martin
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1160.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.